DJIA 16,102.38 -272.38 -1.66%
NASDAQ 4,683.92 -49.58 -1.05%
S&P 500 1,921.22 -29.91 -1.53%
market minute promo

Keryx Biopharmaceuticals (NASDAQ: KERX)

4.76 -0.30 (-5.93%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

KERX $4.76 -5.93%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.98
Previous Close $5.06
Daily Range $4.59 - $4.99
52-Week Range $4.59 - $18.30
Market Cap $500.6M
P/E Ratio -3.72
Dividend (Yield) $0.00 (0.0%)
Volume 4,019,432
Average Daily Volume 1,794,297
Current FY EPS -$1.01




Drug Makers

Keryx Biopharmaceuticals (KERX) Description

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Website:

News & Commentary

Why Shares of Keryx Biopharmaceuticals Fell Hard Today

Downbeat analyst coverage mixed with a low price target sends the company's stock down hard.

Battleground: Will This $5 Biotech Stock Go To $22 Or $1.50?

Thursday's ETF Movers: VLUE, XBI

Thursday Sector Laggards: Drugs, Biotechnology Stocks

Mid-Day Market Update: Joy Global Drops On Earnings Miss; Methode Electronics Shares Spike Higher

Mid-Morning Market Update: Markets Gain; Campbell Soup Earnings Top Estimates

Watch For A Potential 50% Drop In Omeros

3 Battleground Biotech Stocks I Would Avoid at All Costs

Arena Pharmaceuticals, Amarin Corp., and Keryx Biopharmaceuticals each have relatively new drugs that once captured the market's imagination. With their real world success in doubt, though, investors might be wise to jump ship now.

This Week In Pharma: Keryx's Sluggish Drug Launch Vs. Excitement At Valeant And Palatin

Insider Trading Alert - WPX, MBI And KERX Traded By Insiders

See More KERX News...

KERX's Top Competitors

KERX $4.76 (-5.93%)
Current stock: KERX
AMGN $147.02 (-1.48%)
Current stock: AMGN
GILD $102.06 (0.15%)
Current stock: GILD
BIIB $302.26 (0.21%)
Current stock: BIIB